Cook® Regentec Announces First U.S. Clinical Use of Advance® CS Coronary Sinus Infusion Catheter to Deliver a Therapeutic in Heart Failure Patients

INDIANAPOLIS /PRNewswire/ -- Cook Regentec announced today the first clinical use in the United Statesof the Advance CS Coronary Sinus Infusion Catheter and Compass® CT Disposable Pressure Transducer to deliver a therapeutic in heart failure patients.

The Advance CS Coronary Sinus Infusion Catheter is a percutaneous balloon infusion catheter designed for use in retrograde coronary sinus infusion (RCSI) procedures. It is used to infuse therapeutic agents into the heart via the coronary venous system. The Compass CT Disposable Pressure Transducer provides continuous monitoring of infusion pressure and pressure in the patient's heart during the procedure.

"Using the Advance CS Coronary Sinus Infusion Catheter, clinicians can deliver therapeutics, including cell and gene therapies, in an out-patient setting," said Amit N Patel, MD, MS, chief of Cardiac Surgery at the University of MiamiHealth System who proctored the U.S. clinical use of the Cook devices. "What we once performed on patients through invasive surgery can now be done in a minimally invasive procedure, lowering medical costs, increasing patient safety and delivering the most effective biologics to treat each patient. In the evolution of gene and cell therapies, this is a revolutionary medical device for both clinicians and patients."

The Advance CS Coronary Sinus Infusion Catheter is intended for temporary occlusion of the coronary sinus for infusion of contrast media, drugs, and therapeutic agents, or possible introduction of devices into the coronary venous system. For more information visit www.regendevices.com.

The Compass CT Disposable Pressure Transducer, a disposable pressure transducer featuring an integrated digital display, monitors physiological pressure and displays pressure during the infusion of therapeutic agents. For more information visit www.cookregentec.com.


Media Contact: Mara Neal at info@cookregentec.com.

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Cook Regentec

Cook Regentec is an Indianapolis, Indiana-based company that develops research and clinical tools to advance regenerative medicine therapies from the lab to the patient. Its product lines cover expansion, packaging, storing, thawing, delivering and processing.